- Home
- MOLN vs SMHI Comparison
MOLN vs SMHI Comparison
Compare MOLN & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- SMHI
- Stock Information
- Founded
- MOLN 2004
- SMHI 1989
- Country
- MOLN Switzerland
- SMHI United States
- Employees
- MOLN N/A
- SMHI N/A
- Industry
- MOLN
- SMHI Marine Transportation
- Sector
- MOLN
- SMHI Consumer Discretionary
- Exchange
- MOLN Nasdaq
- SMHI Nasdaq
- Market Cap
- MOLN 192.4M
- SMHI 191.3M
- IPO Year
- MOLN 2021
- SMHI N/A
- Fundamental
- Price
- MOLN $5.04
- SMHI $7.00
- Analyst Decision
- MOLN
- SMHI
- Analyst Count
- MOLN 0
- SMHI 0
- Target Price
- MOLN N/A
- SMHI N/A
- AVG Volume (30 Days)
- MOLN 5.7K
- SMHI 157.4K
- Earning Date
- MOLN 03-13-2025
- SMHI 02-27-2025
- Dividend Yield
- MOLN N/A
- SMHI N/A
- EPS Growth
- MOLN N/A
- SMHI N/A
- EPS
- MOLN N/A
- SMHI N/A
- Revenue
- MOLN $7,105,397.00
- SMHI $274,636,000.00
- Revenue This Year
- MOLN N/A
- SMHI $6.04
- Revenue Next Year
- MOLN $29.41
- SMHI $11.18
- P/E Ratio
- MOLN N/A
- SMHI N/A
- Revenue Growth
- MOLN N/A
- SMHI 3.89
- 52 Week Low
- MOLN $3.32
- SMHI $5.80
- 52 Week High
- MOLN $12.70
- SMHI $15.36
- Technical
- Relative Strength Index (RSI)
- MOLN 41.97
- SMHI 54.68
- Support Level
- MOLN $5.22
- SMHI $6.68
- Resistance Level
- MOLN $5.35
- SMHI $7.20
- Average True Range (ATR)
- MOLN 0.12
- SMHI 0.32
- MACD
- MOLN -0.03
- SMHI 0.00
- Stochastic Oscillator
- MOLN 0.00
- SMHI 53.75
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides world-wide marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations including wind farms; handle anchors and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico); Africa and Europe; Middle East and Asia and Latin America.